Dr. Mark Einzig

D.D.S. | Dentist



  
  90 Grove Street, Suite 208, Ridgefield
  Connecticut, 06877

  203-438-0120    Maps & Directions
Dr. Mark Einzig is a Ridgefield, Connecticut based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 90 Grove Street, Suite 208, Ridgefield. Patients can reach him at 203-438-0120.
Dr. Mark Einzig is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Mark Einzig speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Mark Einzig
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:90 Grove Street, Suite 208, Ridgefield,
Connecticut, 06877
Phone:203-438-0120
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 2466773437
Enrollment ID: I20150602002133
NPI Number: 1215024245
NPI Enumeration Date: 10 Oct, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 90 Grove Street, Suite 208
Ridgefield, Connecticut
Zip: 06877
Phone Number: 203-438-0120
Patients can reach Dr. Mark Einzig at 90 Grove Street, Suite 208, Ridgefield, Connecticut or can call to book an appointment on 203-438-0120. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.

Comments/ Reviews: